These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 14645020)

  • 21. Effects of antidepressant treatments on health service utilization and medical costs among patients with depression: a nationwide population-based retrospective cohort study in Taiwan.
    Su KP; Tang CH; Chang HC; Chiu WC; Lu N; Huang KC
    Int Clin Psychopharmacol; 2019 Jul; 34(4):170-178. PubMed ID: 30964763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide.
    Freemantle N; House A; Song F; Mason JM; Sheldon TA
    BMJ; 1994 Jul; 309(6949):249-53. PubMed ID: 7832842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.
    Anderson IM; Tomenson BM
    BMJ; 1995 Jun; 310(6992):1433-8. PubMed ID: 7613276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression and pain: an appraisal of cost effectiveness and cost utility of antidepressants.
    Pan YJ; Pan CH; Chan HY; Kuo KH
    J Psychiatr Res; 2015 Apr; 63():123-31. PubMed ID: 25727051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of conflict of interest in economic analyses of new drugs used in oncology.
    Friedberg M; Saffran B; Stinson TJ; Nelson W; Bennett CL
    JAMA; 1999 Oct; 282(15):1453-7. PubMed ID: 10535436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Expenditure, Price, and Utilization in the U.S. Medicaid: A Trend Analysis for SSRI and SNRI Antidepressants from 1991 to 2018.
    Alrasheed M; Hincapie AL; Guo JJ
    J Ment Health Policy Econ; 2021 Mar; 24(1):3-11. PubMed ID: 33739932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacoeconomic evaluation of antidepressant therapies.
    Sarnes MW; Frankum LE
    Manag Care; 2004 Jun; 13(6 Suppl Depression):34-41. PubMed ID: 15293769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2000; (4):CD002791. PubMed ID: 11034764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SSRIs vs tricyclic antidepressants.
    Griffin GH
    J Fam Pract; 1996 Feb; 42(2):110. PubMed ID: 8606296
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of antidepressants among elderly subjects: trends and contributing factors.
    Mamdani MM; Parikh SV; Austin PC; Upshur RE
    Am J Psychiatry; 2000 Mar; 157(3):360-7. PubMed ID: 10698810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
    Edwards SJ; Hamilton V; Nherera L; Trevor N
    Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duloxetine versus other anti-depressive agents for depression.
    Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
    Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants in major depressive disorder in Italy.
    Mencacci C; Aguglia E; Biggio G; Cappellari L; Di Sciascio G; Fagiolini A; Maina G; Tortorella A; Katz P; Ripellino C
    Adv Ther; 2013 Jul; 30(7):697-712. PubMed ID: 23929174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choosing an antidepressant: effectiveness based pharmacoeconomics.
    Stewart A
    J Affect Disord; 1998 Mar; 48(2-3):125-33. PubMed ID: 9543201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant use among elderly patients.
    Flint A; Silveira J
    Am J Psychiatry; 2001 Feb; 158(2):328-30. PubMed ID: 11156834
    [No Abstract]   [Full Text] [Related]  

  • 36. Quality of treatment: what do new antidepressants offer?
    Lader M
    Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 1():5-9. PubMed ID: 7622812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased use of antidepressants in Wuhan, China: a retrospective study from 2006 to 2012.
    Gao P; Zhang H; Xu H; Zhang C; Liu D
    Medicina (Kaunas); 2013; 49(12):529-34. PubMed ID: 24858993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-year costs of second-line therapies for depression.
    Sullivan EM; Griffiths RI; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    J Clin Psychiatry; 2000 Apr; 61(4):290-8. PubMed ID: 10830151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health economic evaluations of antidepressants: a review.
    Hylan TR; Buesching DP; Tollefson GD
    Depress Anxiety; 1998; 7(2):53-64. PubMed ID: 9614592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis.
    Krauth D; Anglemyer A; Philipps R; Bero L
    PLoS Biol; 2014 Jan; 12(1):e1001770. PubMed ID: 24465178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.